Harrisburg, NC -- (SBWIRE) -- 03/05/2019 -- The report Global Glaucoma Market analyzes the development of this market, with focus on the US and OUS treatment market. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Pfizer Inc., Novartis AG, Merck & Co., Inc. and Allergan Plc. are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global glaucoma market along with the study of the US market.
The market research report presents a comprehensive assessment of the market and contains qualitative and quantitative insights, historical and forecasted data, competitor and regional analysis. The research report provides analysis and information according to categories such as market segments, geographies, types and applications.
These major players have adopted various organic as well as inorganic growth strategies such as mergers and acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
Order a Copy of This Report (USD $800) at:
https://www.marketinsightsreports.com/report/purchase/02121092919?mode=su?source=releasewire&Mode=12
Following are major Table of Content of Glaucoma Industry:
- Glaucoma Market Sales Overview.
- Glaucoma Market Sales Competition by Manufacturers.
- Glaucoma Market Sales Analysis by Region.
- Glaucoma Market Sales Analysis by Type.
- Glaucoma Market Analysis by Application.
- Glaucoma Market -Manufacturers Analysis.
This independent 70 pages report guarantees you will remain better informed than your competition. With over 50 tables and figures examining the Glaucoma market, the report gives you a visual, one-stop breakdown of the leading products, submarkets and market leader's market revenue forecasts as well as analysis to 2021.
Furthermore, the report provides a detailed analysis of the global Glaucoma market with analysis of market size by value and volume. Along with this, an analysis of penetration rate and the average revenue generated per user (ARPU) in the market has also been done.
Request Sample Copy of this Report:
https://www.marketinsightsreports.com/reports/02121092919/global-glaucoma-market-industry-analysis-outlook-2017-2021/inquiry?source=releasewire&Mode=12
Glaucoma is a group of eye diseases which result in damage to the optic nerve and vision loss. The most common type is open-angle glaucoma with less common types including closed-angle glaucoma and normal-tension glaucoma. Open-angle glaucoma develops slowly over time and there is no pain. Side vision may begin to decrease followed by central vision resulting in blindness, if not treated. Closed-angle glaucoma can present gradually or suddenly. The sudden presentation may involve severe eye pain, blurred vision, mid-dilated pupil, redness of the eye, and nausea. Vision loss from glaucoma, once it has occurred, is permanent.
Though, glaucoma cannot be cured completely but the disease progression can be controlled with the help of available treatments. There are three types of modalities available for treatment of glaucoma: Drugs, Laser and Invasive Surgery. Further, based upon the approaches employed for the medication, it can be segmented into two parts: PGA Medication and Non-PGA Medication. The PGA approach reduces IOP with the help of prostaglandin (PGA). The non-PGA medication can be further divided into four sub segments: Beta blockers, Alpha blockers, Carbonic anhydrase inhibitors (CAIs) and Combination Products.
Several factors such as rising prevalence of diabetes, growing geriatric population and rising health care expenditure along with increasing disposable income and growing obese population will drive the market growth in the next few years. Development of new drugs & devices and drug therapy focused upon IOP are the few notable market trends. However, high cost of treatment, severe side effects and hasty drug approval processes act as a major roadblock for the market growth.
Browse Full Report at:
https://www.marketinsightsreports.com/reports/02121092919/global-glaucoma-market-industry-analysis-outlook-2017-2021?source=releasewire&Mode=12
Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share and contact information. What's more, the Glaucoma industry development trends and marketing channels are analyzed.
The research includes historic data from 2013 to 2017 and forecasts until 2021 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs. The report will make detailed analysis mainly on above questions and in-depth research on the development environment, market size, development trend, operation situation and future development trend of Glaucoma on the basis of stating current situation of the industry in 2018 so as to make comprehensive organization and judgment on the competition situation and development trend of Glaucoma Market and assist manufacturers and investment organization to better grasp the development course of Glaucoma Market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Contact US:
Irfan Tamboli (Head of Sales)
Market Insights Reports
Phone: + 1704 266 3234 | Mob: +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com